Average Co-Inventor Count = 5.58
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Research Technology Limited (5 from 262 patents)
2. Københavns Universitet (4 from 27 patents)
3. Go Therapeutics, Inc. (3 from 7 patents)
4. Kobenhavns Univerrsitet (1 from 1 patent)
8 patents:
1. 11860165 - CORE3-MUC1 binding polypeptides and uses thereof
2. 11067578 - Tn-MUC4 binding polypeptides and uses thereof
3. 10919973 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
4. 10139414 - Tn-MUC4 binding polypeptides and uses thereof
5. 10017576 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
6. 9359436 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
7. 8912311 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
8. 8440798 - Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies